In conclusion, the present work provides the experimental evidence that MR antagonism by spironolactone could attenuate bleomycin-induced acute pulmonary injury and fibrosis, partially by reducing circulating inflammatory Ly6Chi monocyte expansion and inhibiting alternatively activation of mononuclear phagocyte in alveolar compartment. The gene discussed is NR3C2; the disease is fibrosis.